|
|
 |
Scientific Advisors
Prof. Britton Chance
Prof. Britton Chance, Chairman of the
Advisory Board, is the founder and patent
holder of the key technology. He obtained
two doctorates of philosophy, one in
physical chemistry from the University of
Pennsylvania (Philadelphia, PA) in 1940, and
the other in biology and physiology from
Cambridge University (Cambridge, UK) in
1943. Between 1941 and 1945, Dr. Chance was
involved in the war effort, focusing on
radar. He went to the MIT Radiation Lab and
was named group leader of the Precision
Circuits Section of the Receiver Components
group in 1943 and was elected to the
steering committee. By 1945 he was associate
director of Lee Haworth's division of the
Radiation Lab. Among Dr. Chance's
achievements were the development of
precision circuits to measure the
submicrosecond time delays between the
emission of a radar pulse and the detection
of its echo. This device provided critical
ranging information for anti-aircraft
gun-pointing systems. His contributions to
the development of radar were recognized in
1950, when he received the Presidential
Certificate of Merit. Since 1949 Dr. Chance
has been Professor of Biophysics and
Director of the Eldridge Reeves Johnson
Foundation for Medical Physics at the
University of Pennsylvania (USA). He has
published more than 2,000 scientific
articles and numerous books covering many
fields of biochemistry, biophysics and
physiology. Dr. Chance is a leading
researcher in biochemistry and biophysics
whose contributions have opened new fields
and have sharpened and changed the way
researchers think about old problems. Dr.
Chance's research extends into other fields
of science, particularly electronics,
clinical medicine, and physics. Throughout
his career, he has attained groundbreaking
ideas and techniques from the whole of
science and redirected the effort toward a
critical problem that benefits from his
integrating approach. He is a member of the
National Academy of Sciences and of the
Institute of Medicine and is a Foreign
Member of the Royal Society of London. Among
many other recognitions, he has received the
National Medal of Science, the Benjamin
Franklin Medal from the American
Philosophical Society, the Biological
Physics Prize from the American Physical
Society, and honorary degrees from the
Karolinska Institut, the Medical College of
Ohio at Toledo, Semmelweis University,
Hahnemann Medical College and the
Universities of Pennsylvania, Helsinki,
Dusseldorf and Buenos Aires.
Dr. Kambiz Pourrezaei
Dr. Pourrezaei earned his Ph.D.
from
Rensselaer Polytechic University in 1982.
His research interests are concentrated in
the areas of biomedical and pharmaceutical
applications of nano and micro technology.
He is actively researching near infrared
(NIR) imaging of biological tissues for
breast cancer and brain imaging. His
research also involves the use of
microtechnology for studying the attachment
of protein and cells to biomaterial
surfaces.
Dr. Pourrezaei is leading the research
activity in the School of Biomedical
Engineering, Science and Health Systems that
is enabling nanotechnology to merge with
biomedical applications. Three major thrust
areas identified by the School include
biosensors, drug delivery, and tissue
engineering. These activities are being
funded by a $10.5 million research grant
that Dr. Pourrezaei, along with Dr. David
Luzzi of the University of Pennsylvania,
recently received from the State of
Pennsylvania to establish the Nanotechnology
Institute (NTI), while support from the
region's pharmaceutical companies is also
energizing this research. NTI has helped
more than 40 faculty members at area
colleges, universities, and hospitals to
land approximately $60 million in federal
research grants. It also has helped spur the
creation of seven companies, drawn praise
from the head of the federal government's
effort to promote nanotech research, and
fielded inquiries from New York financiers
interested in nanotechnology investment
opportunities in the region. Though many
areas have launched various efforts to
capitalize on nanotechnology, NTI is the
first to focus on building partnerships
among businesses and academic institutions,
as specifically noted by Mihail C. Roco,
senior advisor for nanotechnology at the
National Science Foundation (NSF).
Dr. Pourrezaei also leads the School's
research activity in the area of bio-optics.
Currently, a near infrared (NIR) modality is
being utilized for monitoring breast cancer
and brain activities. The projects are being
funded by various federal government
agencies, including the National Institutes
of Health (NIH).
Business Advisors
Wharton VIP Program |
|
